Physostigmine in Alzheimer's disease

Lancet. 1979 Jan 6;1(8106):42. doi: 10.1016/s0140-6736(79)90479-3.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Alzheimer Disease / physiopathology*
  • Clinical Trials as Topic
  • Dementia / physiopathology*
  • Drug Evaluation
  • Humans
  • Injections, Subcutaneous
  • Intelligence Tests
  • Male
  • Memory / drug effects
  • Memory Disorders / drug therapy*
  • Neuropsychological Tests
  • Physostigmine / administration & dosage*
  • Placebos
  • Research Design

Substances

  • Placebos
  • Physostigmine